In this study, we identified plasma mRNA levels of SETD2 and DDX11 as candidate markers for predicting the prognosis of ccRCC, and developed prediction models for high-grade ccRCC based on the mRNA levels of SETD2 and DDX11 in frozen tissues and plasma samples. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.